XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://biotechstocks.com/new-science-may-make-deleting-bad-memories-possible/20%Monthly2017-02-28 20:55
https://biotechstocks.com/amgn-trial-showed-kyprolis-carfilzomib-significantly-improved-overall-survival/20%Monthly2017-02-28 14:13
https://biotechstocks.com/kite-form-8-k-9/20%Monthly2017-02-28 14:10
https://biotechstocks.com/kite-form-10-k-2/20%Monthly2017-02-28 14:06
https://biotechstocks.com/kite-reports-fourth-quarter-and-full-year-2016-financial-results/20%Monthly2017-02-28 14:03
https://biotechstocks.com/biomarin-pharmaceutical-inc-nasdaqbmrn-logs-a-combined-blockbuster/20%Monthly2017-02-28 07:22
https://biotechstocks.com/mateon-therapeutics-inc-otcmktsmatn-announces-initial-pre-clinical-data-on-combination-of-ca4p-with-checkpoint-inhibitors/20%Monthly2017-02-28 07:19
https://biotechstocks.com/biotech-stock-news-incyte-inks-deal-with-abramson-cancer-center-to-advance-research/20%Monthly2017-02-28 04:10
https://biotechstocks.com/amgen-inc-nasdaqamgn-in-deal-with-harvard-pilgrim-in-a-bid-to-safeguard-one-of-the-top-biotech-stocks-drugs-market-share-2/20%Monthly2017-02-28 04:00
https://biotechstocks.com/amgen-inc-nasdaqamgn-in-deal-with-harvard-pilgrim-in-a-bid-to-safeguard-one-of-the-top-biotech-stocks-drugs-market-share/20%Monthly2017-02-28 03:55
https://biotechstocks.com/techshot-inc-working-on-new-medical-technology-for-soldiers-and-space-travel/20%Monthly2017-02-27 20:53
https://biotechstocks.com/regn-to-present-new-data-on-dupixent/20%Monthly2017-02-27 14:01
https://biotechstocks.com/lbio-to-present-at-upcoming-investor-conferences-in-march/20%Monthly2017-02-27 13:55
https://biotechstocks.com/adxs-announce-licensing-agreement/20%Monthly2017-02-27 13:53
https://biotechstocks.com/invest-or-sell-in-biotech-stock-gilead-sciences-inc-nasdaqgild/20%Monthly2017-02-27 13:33
https://biotechstocks.com/peregrine-pharmaceuticals-nasdaqpphm-subsidiary-to-participate-at-life-sciences-industry-conferences/20%Monthly2017-02-27 13:28
https://biotechstocks.com/will-argos-therapeutics-inc-nasdaqargs-stop-carcinoma-study/20%Monthly2017-02-27 13:24
https://biotechstocks.com/auris-medical-holding-ag-nasdaqears-updates-on-tinnitus-collaboration/20%Monthly2017-02-27 12:51
https://biotechstocks.com/investors-focus-on-eyegate-pharmaceuticals-inc-nasdaqeyeg/20%Monthly2017-02-27 12:47
https://biotechstocks.com/venom-from-a-sea-snail-could-possibly-replace-opioid-painkillers/20%Monthly2017-02-24 20:32
https://biotechstocks.com/trevena-inc-nasdaqtrvn-prepares-case-for-improved-post-surgical-opioid-with-fresh-trial-report/20%Monthly2017-02-24 07:17
https://biotechstocks.com/heat-biologics-inc-nasdaqhtbx-releases-outlook-on-bladder-cancer-treatment/20%Monthly2017-02-24 07:11
https://biotechstocks.com/valeant-pharmaceuticals-intl-inc-nysevrx-acquires-eyegate-pharmaceuticals-inc-nasdaqeyeg-licensing-rights/20%Monthly2017-02-24 07:05
https://biotechstocks.com/can-amyris-inc-nasdaqamrs-make-a-comeback/20%Monthly2017-02-24 06:54
https://biotechstocks.com/delcath-systems-inc-nasdaqdcth-updates-on-retrospective-multicenter-trial/20%Monthly2017-02-24 06:40
https://biotechstocks.com/drug-resistant-fungal-infection-causes-new-medical-concern/20%Monthly2017-02-23 21:06
https://biotechstocks.com/scientists-may-have-found-a-way-to-predict-future-adolescent-drug-use/20%Monthly2017-02-22 20:54
https://biotechstocks.com/vbiv-receives-positive-response-from-health-canadas-initial-evaluation/20%Monthly2017-02-22 14:22
https://biotechstocks.com/to-participate-at-upcoming-life-sciences-industry-conferences/20%Monthly2017-02-22 14:06
https://biotechstocks.com/amrn-to-report-fourth-quarter-and-full-year-2016-results/20%Monthly2017-02-22 13:58
https://biotechstocks.com/a-close-look-at-clovis-oncology-inc-nasdaqclvs/20%Monthly2017-02-22 09:12
https://biotechstocks.com/auris-medical-holding-ag-nasdaqears-grows-pipeline-with-intranasal-betahistine/20%Monthly2017-02-22 09:08
https://biotechstocks.com/pfizer-inc-nysepfe-in-association-with-celltrion-healthcare-releases-new-data-for-inflectra/20%Monthly2017-02-22 09:04
https://biotechstocks.com/how-oncogenex-pharmaceuticals-inc-nasdaqogxi-will-fare-in-fy2016/20%Monthly2017-02-22 09:01
https://biotechstocks.com/amygdala-neurosciences-inc-acquires-gs-6637-from-gilead-sciences-inc-nasdaqgild/20%Monthly2017-02-22 08:56
https://biotechstocks.com/possible-new-therapy-for-huntingtons-disease-on-the-horizon/20%Monthly2017-02-21 20:14
https://biotechstocks.com/mdvx-provides-corporate-update/20%Monthly2017-02-21 14:09
https://biotechstocks.com/celg-multiple-sclerosis-drug-reported-positive-phase-iii-results/20%Monthly2017-02-21 14:06
https://biotechstocks.com/prtx-update-on-us-and-eu-studies-of-prtx-100/20%Monthly2017-02-21 14:03
https://biotechstocks.com/abo-102-phase-12-trial-by-abeona-therapeutics-inc-nasdaqabeo-has-a-new-update/20%Monthly2017-02-21 11:23
https://biotechstocks.com/amicus-therapeutics-inc-nasdaqfold-announces-positive-preliminary-data-from-phase-12-study-of-novel-treatment-paradigm/20%Monthly2017-02-21 09:16
https://biotechstocks.com/auris-medical-holding-ag-nasdaqears-announces-pricing-of-10-million-public-offering/20%Monthly2017-02-21 09:12
https://biotechstocks.com/celsion-corporation-nasdaqclsn-announces-5-0-million-public-offering/20%Monthly2017-02-21 09:08
https://biotechstocks.com/gilead-sciences-inc-nasdaqgild-receives-approval-in-canada-for-odefsey-for-the-treatment-of-hiv-1-infection/20%Monthly2017-02-21 09:04
https://biotechstocks.com/tesaro-inc-nasdaqtsro-evaluates-its-new-cancer-drug-with-a-5-billion-market-opportunity/20%Monthly2017-02-20 05:39
https://biotechstocks.com/biostage-inc-nasdaqbstg-leading-biotech-stock-firm-aims-to-revolutionise-esophageal-cancer/20%Monthly2017-02-20 05:35
https://biotechstocks.com/amgen-inc-nasdaqamgnis-looking-towards-the-market-for-leukaemia-treatment/20%Monthly2017-02-20 05:30
https://biotechstocks.com/rxi-pharmaceuticals-corp-nasdaqrxii-welcomes-a-new-member-to-the-team-who-will-be-serving-as-medical-oncology-expert/20%Monthly2017-02-20 05:26
https://biotechstocks.com/things-look-up-for-amygdala-biotech-stocks-as-gilead-sciences-inc-nasdaqgild-sells-gs-6637/20%Monthly2017-02-20 05:17
https://biotechstocks.com/celg-form-8-k-14/20%Monthly2017-02-17 13:49
https://biotechstocks.com/peregrine-pharmaceuticals-nasdaqpphm-top-biotech-stocks-biotech-stock-peregrine-pharmaceuticals/20%Monthly2017-02-17 07:47
https://biotechstocks.com/bioline-rx-ltd-nasdaqblrx-boasts-strong-balance-sheet-2/20%Monthly2017-02-17 07:40
https://biotechstocks.com/alexion-pharmaceuticals-inc-nasdaqalxn-4q2016-revenue-jumps-19-2/20%Monthly2017-02-17 07:37
https://biotechstocks.com/alexion-pharmaceuticals-inc-nasdaqalxn-4q2016-revenue-jumps-19/20%Monthly2017-02-17 07:32
https://biotechstocks.com/bioline-rx-ltd-nasdaqblrx-boasts-strong-balance-sheet/20%Monthly2017-02-17 07:25
https://biotechstocks.com/gilead-sciences-inc-nasdaqgild-posts-strong-data-from-phase-ii-drug-combo-trial/20%Monthly2017-02-16 14:24
https://biotechstocks.com/celsion-corporation-nasdaqclsn-reports-5-million-public-offering/20%Monthly2017-02-16 14:23
https://biotechstocks.com/why-editas-medicine-inc-nasdaqedit-comes-in-list-of-top-biotech-stocks/20%Monthly2017-02-16 14:22
https://biotechstocks.com/biotech-stock-news-auris-medical-holding-ag-nasdaqears/20%Monthly2017-02-16 14:22
https://biotechstocks.com/why-amgen-inc-nasdaqamgn-is-a-top-biotech-stock-pick/20%Monthly2017-02-16 14:21
https://biotechstocks.com/alxn-form-8-k-7/20%Monthly2017-02-16 14:14
https://biotechstocks.com/cur-announces-last-subject-enrolled-in-phase-2-trial-with-nsi-189-2/20%Monthly2017-02-16 14:10
https://biotechstocks.com/how-to-prevent-more-deaths-every-year/20%Monthly2017-02-15 20:29
https://biotechstocks.com/mdvx-completes-phase-ii-ce-mark-audit-with-notified-body-lnegmed/20%Monthly2017-02-15 13:43
https://biotechstocks.com/lawsuit-case-against-galena-biopharma-inc-nasdaqgale-claiming-that-they-misled-shareholders/20%Monthly2017-02-15 13:40
https://biotechstocks.com/agenus-inc-nasdaqagen-and-incyte-corporation-nasdaqincy-are-working-on-amending-their-licensing-deals/20%Monthly2017-02-15 13:36
https://biotechstocks.com/the-future-of-the-biotech-and-healthcare-sector-in-2017/20%Monthly2017-02-14 20:53
https://biotechstocks.com/ino-collaboration-and-license-deal-with-apollobio-for-greater-china/20%Monthly2017-02-14 14:12
https://biotechstocks.com/cytx-provides-latest-corporate-update/20%Monthly2017-02-14 14:09
https://biotechstocks.com/zosana-pharma-corp-nasdaqzsan-transdermal-therapeutic-satisfies-both-co-primary-endpoints-in-the-zotrip-pivotal-efficacy-trial/20%Monthly2017-02-14 13:23
https://biotechstocks.com/northwest-biotherapeutics-inc-otcmktsnwbo-brain-cancer-immunotherapy-suspension-has-been-lifted-by-the-fda/20%Monthly2017-02-14 13:17
https://biotechstocks.com/is-there-really-a-cure-for-cancer/20%Monthly2017-02-13 21:52
https://biotechstocks.com/tech-to-present-at-the-6th-annual-global-healthcare-conference/20%Monthly2017-02-13 13:57
https://biotechstocks.com/halo-studies-lead-investigational-drug-mvt-5873/20%Monthly2017-02-13 13:49
https://biotechstocks.com/portola-pharmaceuticals-inc-nasdaq-ptla-sell-royalty-rights-to-andexxa-for-150-million/20%Monthly2017-02-13 10:14
https://biotechstocks.com/peregrine-pharmaceuticals-nasdaqpphm-cancer-test-clears-proof-of-concept/20%Monthly2017-02-13 09:39
https://biotechstocks.com/7-medical-breakthroughs-in-2k17-that-will-shock-the-world/20%Monthly2017-02-10 20:52
https://biotechstocks.com/regn-positive-data-from-parkinson-disease-late-stage-clinical-trial/20%Monthly2017-02-10 14:05
https://biotechstocks.com/celg-form-10-k/20%Monthly2017-02-10 13:55
https://biotechstocks.com/peregrine-pharmaceuticals-nasdaqpphm-announces-positive-data-for-cancer-detection-technology/20%Monthly2017-02-10 10:36
https://biotechstocks.com/jaguar-animal-health-inc-nasdaqjagx-merges-with-napo-pharmaceuticals/20%Monthly2017-02-10 10:34
https://biotechstocks.com/improved-scaffolds-help-investigative-researhers-study-cancer/20%Monthly2017-02-09 20:47
https://biotechstocks.com/pphm-highlights-proof-of-concept-data/20%Monthly2017-02-09 14:49
https://biotechstocks.com/aldr-to-present-at-the-6th-annual-global-healthcare-conference/20%Monthly2017-02-09 14:42
https://biotechstocks.com/regn-form-8-k-9/20%Monthly2017-02-09 14:41
https://biotechstocks.com/rxi-pharmaceuticals-corp-nasdaqrxii-appoints-new-leading-oncology-expert-and-is-expected-to-present-at-upcoming-healthcare-conferences/20%Monthly2017-02-09 10:58
https://biotechstocks.com/opko-health-inc-nasdaqopk-announces-strategic-plans-for-coming-quarter-including-starting-a-new-trial-and-hiring-new-chief-commercial-officer/20%Monthly2017-02-09 10:55
https://biotechstocks.com/could-food-poison-be-good-for-cancer/20%Monthly2017-02-08 20:54
https://biotechstocks.com/is-there-an-efficacy-concern-with-mannkind-corporation-nasdaqmnkd/20%Monthly2017-02-08 15:16
https://biotechstocks.com/gilead-sciences-inc-nasdaqgild-4q2016-product-sales-at-7-2-billion/20%Monthly2017-02-08 15:12
https://biotechstocks.com/adhd-to-release-fiscal-2016-financial-results/20%Monthly2017-02-08 14:10
https://biotechstocks.com/7-methods-to-reduce-heart-problems/20%Monthly2017-02-07 20:34
https://biotechstocks.com/what-happens-when-medicine-goes-bad/20%Monthly2017-02-06 20:40
https://biotechstocks.com/aria-submission-of-marketing-authorization-application-for-brigatinib/20%Monthly2017-02-06 14:07
https://biotechstocks.com/tenax-therapeutics-inc-nasdaqtenxs-phase-3-trial-in-cardiac-surgery-failed-to-achieve-dual-endpoint/20%Monthly2017-02-06 08:22
https://biotechstocks.com/cerulean-pharma-inc-nasdaqcerus-stock-on-rollercoaster-on-account-of-merger-deal/20%Monthly2017-02-06 08:19
https://biotechstocks.com/the-launch-of-a-new-titration-pack-by-mannkind-corporation-nasdaqmnkd-will-accelerate-the-growth-of-afrezza/20%Monthly2017-02-03 14:04
https://biotechstocks.com/the-direct-offering-by-pulmatrix-inc-nasdaqpulm-will-cost-5-0-million/20%Monthly2017-02-03 14:00
https://biotechstocks.com/could-a-cure-for-hiv-happen-in-the-near-future/20%Monthly2017-02-02 21:04
https://biotechstocks.com/jaguar-animal-health-inc-nasdaqjagx-finalizes-a-deal-with-elanco/20%Monthly2017-02-02 13:50
https://biotechstocks.com/what-is-wrong-with-catabasis-pharmaceuticals-inc-nasdaqcatb/20%Monthly2017-02-02 13:47
https://biotechstocks.com/educate-yourself-on-cancer-before-it-kills-you/20%Monthly2017-02-01 20:57
https://biotechstocks.com/tenax-therapeutics-inc-nasdaqtenx-reports-top-line-report-from-phase-iii-levo-cts-trial/20%Monthly2017-02-01 13:04
https://biotechstocks.com/gilead-sciences-inc-nasdaqgild-shareholders-eagerly-await-quarterly-results/20%Monthly2017-02-01 12:55